These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28926587)

  • 1. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.
    Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV
    PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
    Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
    J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
    Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
    Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.
    Holdener BC; Percival CJ; Grady RC; Cameron DC; Berardinelli SJ; Zhang A; Neupane S; Takeuchi M; Jimenez-Vega JC; Uddin SMZ; Komatsu DE; Honkanen R; Dubail J; Apte SS; Sato T; Narimatsu H; McClain SA; Haltiwanger RS
    Hum Mol Genet; 2019 Dec; 28(24):4053-4066. PubMed ID: 31600785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report.
    Wang YE; Ramirez DA; Chang TC; Berrocal A
    BMC Ophthalmol; 2020 Mar; 20(1):118. PubMed ID: 32204707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of a Novel
    Totoń-Żurańska J; Kapusta P; Rybak-Krzyszkowska M; Lorenc K; Machlowska J; Skalniak A; Filipek E; Pawlik D; Wołkow PP
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
    Weh E; Reis LM; Tyler RC; Bick D; Rhead WJ; Wallace S; McGregor TL; Dills SK; Chao MC; Murray JC; Semina EV
    Clin Genet; 2014 Aug; 86(2):142-8. PubMed ID: 23889335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocephalus in mouse B3glct mutants is likely caused by defects in multiple B3GLCT substrates in ependymal cells and subcommissural organ.
    Neupane S; Goto J; Berardinelli SJ; Ito A; Haltiwanger RS; Holdener BC
    Glycobiology; 2021 Sep; 31(8):988-1004. PubMed ID: 33909046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
    Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
    Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput miRFluR Platform Identifies miRNA Regulating B3GLCT That Predict Peters' Plus Syndrome Phenotype, Supporting the miRNA Proxy Hypothesis.
    Thu CT; Chung JY; Dhawan D; Vaiana CA; Mahal LK
    ACS Chem Biol; 2021 Oct; 16(10):1900-1907. PubMed ID: 34085516
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang A; Berardinelli SJ; Leonhard-Melief C; Vasudevan D; Liu TW; Taibi A; Giannone S; Apte SS; Holdener BC; Haltiwanger RS
    J Biol Chem; 2020 Nov; 295(46):15742-15753. PubMed ID: 32913123
    [No Abstract]   [Full Text] [Related]  

  • 12. Peters Plus syndrome: a recognizable clinical entity.
    Demir GÜ; Lafcı NG; Doğan ÖA; Şimşek-Kiper PÖ; Utine GE
    Turk J Pediatr; 2020; 62(1):136-140. PubMed ID: 32253880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure.
    Siala O; Belguith N; Kammoun H; Kammoun B; Hmida N; Chabchoub I; Hchicha M; Fakhfakh F
    Gene; 2012 Oct; 507(1):68-73. PubMed ID: 22759511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays.
    Berardinelli SJ; Haltiwanger RS
    Methods Mol Biol; 2020; 2043():25-43. PubMed ID: 31463900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.
    Dubail J; Vasudevan D; Wang LW; Earp SE; Jenkins MW; Haltiwanger RS; Apte SS
    Sci Rep; 2016 Sep; 6():33974. PubMed ID: 27687499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Phenotype of Peters-Plus Syndrome.
    Shah PR; Chauhan B; Chu CT; Kofler J; Nischal KK
    Cornea; 2022 Feb; 41(2):219-223. PubMed ID: 34629439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells.
    Lauwen S; Baerenfaenger M; Ruigrok S; de Jong EK; Wessels HJCT; den Hollander AI; Lefeber DJ
    Exp Eye Res; 2021 Dec; 213():108798. PubMed ID: 34695439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrocephalus, agenesis of the corpus callosum, and cleft lip/palate represent frequent associations in fetuses with Peters' plus syndrome and B3GALTL mutations. Fetal PPS phenotypes, expanded by Dandy Walker cyst and encephalocele.
    Schoner K; Kohlhase J; Müller AM; Schramm T; Plassmann M; Schmitz R; Neesen J; Wieacker P; Rehder H
    Prenat Diagn; 2013 Jan; 33(1):75-80. PubMed ID: 23161355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic, cDNA and embryonic expression analysis of zebrafish IRF6, the gene mutated in the human oral clefting disorders Van der Woude and popliteal pterygium syndromes.
    Ben J; Jabs EW; Chong SS
    Gene Expr Patterns; 2005 Jun; 5(5):629-38. PubMed ID: 15939375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats.
    Heinonen TY; Maki M
    Ann Med; 2009; 41(1):2-10. PubMed ID: 18720094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.